Here's the Biotech Pfizer Should Consider Acquiring Next

Motley Fool2021-09-03

Kudos to Pfizer (NYSE:PFE) for its decision to acquire Trillium Therapeutics (NASDAQ:TRIL). The small biotech's cancer pipeline is a great fit for Pfizer. Trillium's candidates could begin ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
7